Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
PTC Therapeutics, Inc. - Common Stock
(NQ:
PTCT
)
44.23
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, May 9, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about PTC Therapeutics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
October 26, 2023
Via
Benzinga
Earnings Preview: PTC Therapeutics
October 25, 2023
Via
Benzinga
Why PTC Therapeutics Soared 15% Higher Today
October 19, 2023
The company scored a $1 billion upfront payment for expanding a commercial partnership.
Via
The Motley Fool
Nasdaq Falls 100 Points; AT&T Posts Upbeat Earnings
October 19, 2023
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite falling around 100 points on Thursday. The Dow traded down 0.43% to 33,520.17 while the NASDAQ fell 0.75% to 13,214.04. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
AT&T, Union Pacific, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday
October 19, 2023
U.S. stocks traded slightly higher, with the Nasdaq Composite gaining around 30 points on Thursday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Expert Ratings for PTC Therapeutics
September 19, 2023
Via
Benzinga
Where PTC Therapeutics Stands With Analysts
August 07, 2023
Via
Benzinga
Raymond James Maintains Outperform Rating for PTC Therapeutics: Here's What You Need To Know
August 04, 2023
Via
Benzinga
Why Nokia Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
October 19, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 19, 2023
Via
Benzinga
NASDAQ:PTCT Shareholder Notice: Investigation over Possible Securities Laws Violations by PTC Therapeutics, Inc.
October 10, 2023
San Diego, CA -- (SBWIRE) -- 10/10/2023 -- PTC Therapeutics, Inc. is under investigation over potential securities laws violations in connection with certain financial statements.
Via
SBWire
Earnings Scheduled For August 3, 2023
August 03, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 6, 2023
October 06, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
October 02, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Monday
October 02, 2023
On Monday, 369 companies set new 52-week lows.
Via
Benzinga
Dell Technologies To Rally More Than 15%? Here Are 10 Other Analyst Forecasts For Tuesday
September 19, 2023
Raymond James increased the price target for Vital Energy, Inc. (NYSE: VTLE) from $54 to $67. Raymond James analyst John Freeman maintained an Outperform rating. Vital Energy shares rose 0.5% to $54.37...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 18, 2023
September 18, 2023
Via
Benzinga
Micron Technology To Rally Around 22%? Here Are 10 Other Analyst Forecasts For Monday
September 18, 2023
Piper Sandler cut the price target for IBEX Limited (NASDAQ: IBEX) from $24 to $17. Piper Sandler analyst Arvind Ramnani maintained an Overweight rating. IBEX shares rose 0.3% to close at $13.59 on...
Via
Benzinga
US Stock Futures Edge Higher Amid Cautious Optimism; Analyst Says How Fed Packages Sept. Pause Key For Market Direction
September 18, 2023
US stock futures point to a higher opening on Monday after averages closed nearly flat in the week ended Sept. 15.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
European Authority Gives Thumbs Down To PTC Therapeutics' Duchenne Therapy; Analyst Says It Can Overturn The Challenge
September 15, 2023
Friday morning, the Committee for Medicinal Products for Human Use of the European Medicines Agency gave a negative opinion on the conversion of the conditional marketing authorization to full...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
September 15, 2023
Via
Benzinga
Why Novonix Shares Are Trading Higher By 27%? Here Are Other Stocks Moving In Friday's Mid-Day Session
September 15, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares jumped 127.8% to $0.1269. The company recently reported second-quarter results.
Via
Benzinga
Nasdaq Down Over 1%; US Industrial Output Rises In August
September 15, 2023
U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling more than 1% points on Friday. The Dow traded down 0.52% to 34,727.05 while the NASDAQ fell 1.31% to 13,743.78. The...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Stocks That Hit 52-Week Lows On Friday
September 15, 2023
Friday's session saw 169 companies set new 52-week lows.
Via
Benzinga
PTC Therapeutics, Planet Fitness, Kemper And Other Big Stocks Moving Lower On Friday
September 15, 2023
U.S. stocks traded higher, with the Dow Jones falling around 180 points on Friday. Here are some big stocks recording losses in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2023
September 15, 2023
Via
Benzinga
Dow Dips 100 Points; US Export Prices Rise 1.3% In August
September 15, 2023
U.S. stocks traded lower this morning, with the Dow Jones falling around 100 points on Friday. Following the market opening Friday, the Dow traded down 0.31% to 34,799.50 while the NASDAQ fell 1.09% to...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
PTC Therapeutics Crashes 29% After European Regulators Reject Its Muscular Dystrophy Drug
September 15, 2023
The company is working on a treatment for Duchenne muscular dystrophy.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session
September 15, 2023
Via
Benzinga
Untapped Potential: 3 Stocks Tackling the Toughest Rare Diseases
August 25, 2023
Treating rare diseases is a tough but potentially lucrative business. With clinical trials coming due, here are three stocks to buy.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.